Brighthouse Financial, Inc. research snapshot
BHF AI stock analysis currently reads Brighthouse Financial as a mid-cap life insurance and annuity company trading below book value and below the announced Aquarian Holdings acquisition price of roughly $71 per share. At the July 12, 2026 data cutoff, the reference close was $66.00 with a verified market capitalization near $3.79 billion. The constructive case is a P/B of 0.55x, $6.97 billion in cash against only $3.79 billion in equity market cap, and a pending all-cash buyout. The caution is that GAAP TTM net income was negative, the Q1 2026 revenue decline was 29.4% year-over-year, short interest is elevated near 9.65% of float, and the deal spread suggests the market has doubts about the Aquarian acquisition closing on announced terms. This BHF AI stock analysis is informational research, not investment advice.
Current price
$66.00
Market cap
$3.79 billion
AI score
58 / 100
Rating
Undervalued on book value with a pending buyout offer, but GAAP losses and deal-close uncertainty limit conviction
Trend status
Near the 52-week high of $66.33 with a steady uptrend from the $42 low, but momentum may be capped by the acquisition overhang
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Brighthouse sells annuities and life insurance through independent distributors, generating premium-based revenue with a large in-force block and repeat policyholder premiums. | Medium-high |
| Moat | The moat comes from regulatory licenses, the in-force policy block, distribution relationships, and the MetLife heritage brand. However, the annuity and life insurance market is competitive with low switching costs for new policies. | Medium |
| Management | CEO Eric Steigerwalt has led the post-spinoff strategy, capital return, and the Aquarian sale process. The pending buyout is a definitive liquidity event for shareholders, but management has limited room to influence the outcome. | Medium |
| Financial trend | FY 2025 revenue was $6.77 billion. Q1 2026 revenue fell 29.4% year-over-year to $2.1 billion. TTM GAAP net income was negative at -$167 million. Adjusted operating metrics are more favorable, with forward EPS estimates near $19.41. | Medium-high |
| Valuation | At $66.00, P/B is 0.55x against $119.49 book value per share, P/S is about 0.56x on annual sales, and the stock trades below the announced $71+ acquisition price. Forward P/E of 3.40x signals expected normalized earnings recovery. | Medium |
| Technical trend | BHF has rallied from a 52-week low of $42.07 to near $66.00. The stock is close to its 52-week high of $66.33. Volume is near average and the 50-day trend is positive, but the deal spread may cap upside near the buyout price. | Medium-high |
| Risk level | Key risks are deal failure or repricing of the Aquarian acquisition, GAAP earnings volatility from actuarial assumptions and investment marks, insurance liability duration, interest rate sensitivity, and high short interest of 9.65% of float. | Medium-high |
| AI confidence | High for current price, market-cap math, shares outstanding, book value, and cash position. Medium for forward scenarios because organic earnings analysis is secondary to the acquisition outcome. | High data confidence |
| Investment certainty | Low to medium. BHF is best understood as a special-situation merger arbitrage position, not a classic long-term equity compounding story. The deal spread reflects real risk. | Low-medium |
BHF AI stock forecast
The BHF AI stock forecast centers on the announced Aquarian Holdings acquisition rather than organic earnings growth. The announced all-cash price of $4.1 billion implies about $71 per share based on the verified share count. At the July 12, 2026 cutoff price of $66.00, the deal spread is roughly 7.6%. These scenarios are not a reliable prediction of BHF stock price and assume the deal closes within the expected timeline.
$71 to $75
More likely if the Aquarian acquisition closes at the announced $4.1 billion price or a marginally improved offer, regulatory approvals are obtained without material concessions, and the deal is completed within the expected timeframe.
$62 to $71
Represents a scenario where the acquisition closes but at a modestly adjusted price due to market conditions, regulatory requirements, or financing changes. The stock would trade near the adjusted offer price.
$45 to $55
More likely if the Aquarian acquisition is terminated or blocked by regulators. BHF would revert to trading as a standalone mid-cap life insurer with GAAP losses, declining revenue, and a P/B near or below current levels.
BHF AI technical analysis
BHF technical analysis as of July 12, 2026 shows a stock in a steady uptrend from its October 2025 lows near $42 to the current $66 area, approaching the 52-week high of $66.33. The pattern is a recovery rally supported by the acquisition announcement. Key levels to watch center on the announced buyout price and nearby technical resistance.
| Level | Value | Why it matters |
|---|---|---|
| Resistance (R1) | $71.36 | Implied Aquarian acquisition price at $4.1 billion against 57.45 million shares. Psychological ceiling unless deal improves. |
| Resistance (R2) | $66.33 | Current 52-week high. A clean break above this level would signal strength but upside is capped near the deal price. |
| Support (S1) | $61.09 | Recent 50-day low. A break below this level would suggest deal-spread widening. |
| Support (S2) | $52.87 | Pre-acquisition-announcement support level. A drop below this would signal high deal-failure probability. |
| Support (S3) | $42.07 | 52-week low. Would likely be revisited only if the acquisition is definitively terminated. |
| 50-day MA | $63.50 (est.) | Price is above the 50-day moving average, confirming near-term uptrend. |
| 200-day MA | $57.00 (est.) | Price is well above the 200-day moving average, confirming a medium-term uptrend since the October 2025 low. |
| Volume | ~445K avg. | Average volume with occasional spikes on deal news. Above-average volume on up days is positive. |
BHF AI trading strategy
BHF is primarily a merger-arbitrage situation. A conventional trend-following or mean-reversion strategy is less relevant than a deal-contingent framework. The trading strategy below reflects this special-situation context rather than a standard equity approach. Always do your own due diligence.
The primary strategy is to capture the remaining spread between the current price ($66.00) and the announced acquisition price ($71+). The annualized return depends on the expected deal closing date. Monitor regulatory filings, Aquarian financing, and shareholder vote timelines.
The main risk is deal failure. Position size should reflect the binary nature of this event. Use a stop-loss if the stock breaks below $61 or if negative deal news emerges. Do not add to the position if the spread widens without confirmed deal-progress news.
If trading BHF as a long equity position rather than a merger-arbitrage play, enter on pullbacks to the 50-day moving average near $63.50 with a target near the deal price of $71. Use a trailing stop of 5-7% below entry.
Set an invalidation stop near $59, below both the 50-day MA and key support. Reduce exposure if the 200-day MA near $57 is breached. Avoid holding through any announced regulatory delay.
BHF has low daily volatility relative to small-cap insurers. Mean reversion trades are less effective in the current deal-driven environment. If the stock drifts to the low end of the range near $61-$62, a limited reversion trade into the mid-$60s is possible.
Keep position size small. Mean reversion is secondary to the deal catalyst. Exit immediately if the stock gaps down on acquisition news.
Investment research summary
Brighthouse Financial sells annuities and life insurance products to U.S. consumers through independent distribution channels. Customers pay premiums for retirement income guarantees, death benefits, and protected wealth accumulation. The company earns spread income and fee-based revenue on a large in-force block of policies inherited from MetLife.
The moat is moderate and rests on regulatory licenses, the in-force policy block which provides recurring premium income, and MetLife-origin brand recognition. Switching costs exist for in-force policyholders but are low for new policy purchases. The annuity market is competitive with players like MetLife, Equitable, Jackson Financial, and Fidelity & Guaranty.
The thesis fails if the Aquarian acquisition is terminated or re-priced materially lower. Other failure paths include adverse reserve development on the legacy block, investment losses in the general account, policy lapses exceeding assumptions, or a prolonged low-interest-rate environment that compresses spread income. The high short interest (9.65% of float) signals that some sophisticated investors see risks.
CEO Eric Steigerwalt has led BHF since the 2017 MetLife spinoff through capital optimization, expense management, and the Aquarian sale process. The board and management have pursued a definitive sale as the primary shareholder-value path. Key-person risk is moderate if the deal closes and management departs post-acquisition.
The U.S. life and annuity industry benefits from structural demand driven by Baby Boomer retirement, employer retirement plan growth, and protected-income product adoption. Higher interest rates have improved new-money yields for insurer general accounts. However, the industry faces regulatory change, low organic growth, and competition from alternative retirement solutions.
At $66.00 with $119.49 book value per share, BHF trades at 0.55x P/B, a discount to life-insurer peers (MET at ~1.3x, UNM at ~1.3x). The announced $4.1B buyout at roughly $71/share represents a 7.6% premium to the current price. The margin of safety depends on deal completion. If the deal fails, the stock could trade down to the $45-$55 range, implying material downside.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Current stock price | $66.00 | Yahoo Finance / MarketBeat | July 12, 2026 |
| Market capitalization | $3.79 billion | Yahoo Finance | July 12, 2026 |
| Enterprise value | $6.70 billion | Yahoo Finance | July 12, 2026 |
| Book value per share | $119.49 | MarketBeat | July 12, 2026 |
| Price to book ratio | 0.55x | MarketBeat / financial_rigor.py | July 12, 2026 |
| TTM GAAP EPS | -$3.07 | Yahoo Finance | July 12, 2026 |
| Forward P/E ratio | 3.40x (implied forward EPS ~$19.41) | MarketBeat | July 12, 2026 |
| Total cash and investments | $6.97 billion | Yahoo Finance | July 12, 2026 |
| Debt to equity ratio | 176.33% | Yahoo Finance | July 12, 2026 |
| FY 2025 annual revenue | $6.77 billion | MarketBeat / Wikipedia | July 12, 2026 |
| Q1 2026 revenue | $2.1 billion (down 29.4% YoY) | Yahoo Finance | July 12, 2026 |
| Q1 2026 GAAP EPS | $4.35 (missed $4.57 consensus) | MarketBeat | July 12, 2026 |
| 52-week range | $42.07 to $66.33 | Yahoo Finance | July 12, 2026 |
| Beta (5-year monthly) | 0.87 | Yahoo Finance | July 12, 2026 |
| Shares outstanding | 57.45 million | MarketBeat | July 12, 2026 |
| Short interest (% of float) | 9.65% (10.8 days to cover) | MarketBeat | July 12, 2026 |
| Institutional ownership | 81.24% | MarketBeat | July 12, 2026 |
| Analyst consensus | Reduce (1.80 / 4.0) | MarketBeat | July 12, 2026 |
| Average analyst price target | $60.50 (range: $53-$70) | MarketBeat | July 12, 2026 |
| Announced acquisition price | $4.1 billion (~$71.36/share) | Reuters / SEC filings | July 12, 2026 |
This BHF AI stock analysis page is for informational and educational purposes only. It does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data, forecasts, scenarios, and technical levels are based on publicly available information as of the data cutoff date (July 12, 2026) and may change without notice. Past performance is not indicative of future results. Investing in equities involves risk, including the potential loss of principal. The analysis uses AI-assisted research and should not be relied upon as the sole basis for an investment decision. Please consult a qualified financial advisor before making any investment.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
